These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 4050600)

  • 1. Chemotactic anti-tumor antibodies: in vitro results with four different antibody preparations.
    Obrist R; Obrecht JP; Bast RC; Sandberg AL
    Adv Exp Med Biol; 1985; 186():827-32. PubMed ID: 4050600
    [No Abstract]   [Full Text] [Related]  

  • 2. Conjugation behaviour of different monoclonal antibodies to f-methionyl-leucyl-phenylalanine.
    Obrist R; Schmidli J; Obrecht JP
    Int J Immunopharmacol; 1986; 8(6):629-32. PubMed ID: 3793327
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro effects of IgA on human polymorphonuclear leukocytes.
    Sibille Y; Delacroix DL; Merrill WW; Chatelain B; Vaerman JP
    Adv Exp Med Biol; 1987; 216A():573-9. PubMed ID: 3687543
    [No Abstract]   [Full Text] [Related]  

  • 4. Deactivation of guinea pig pulmonary alveolar macrophage responses to N-formyl-methionyl-leucyl-phenylalanine: chemotaxis, superoxide generation, and binding.
    Daughaday CC; Mehta J; Spilberg I; Atkinson JP
    J Immunol; 1985 Mar; 134(3):1823-6. PubMed ID: 2981922
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhancement of macrophage invasion of tumors by administration of chemotactic factor-antitumor antibody conjugates.
    Obrist R; Sandberg AL
    Cell Immunol; 1983 Oct; 81(1):169-74. PubMed ID: 6651932
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Manipulation of the intratumor infiltrate by anti-tumor antibody conjugates.
    Obrist R
    Biochim Biophys Acta; 1987 Jul; 907(2):175-90. PubMed ID: 3297156
    [No Abstract]   [Full Text] [Related]  

  • 7. Contributions of the Mac-1 glycoprotein family to adherence-dependent granulocyte functions: structure-function assessments employing subunit-specific monoclonal antibodies.
    Anderson DC; Miller LJ; Schmalstieg FC; Rothlein R; Springer TA
    J Immunol; 1986 Jul; 137(1):15-27. PubMed ID: 3519773
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro and in vivo effects of anti-tumor antibody covalently coupled to a chemotactic peptide.
    Sandberg AL; Obrist R; Mergenhagen SE
    Agents Actions Suppl; 1983; 12():234-50. PubMed ID: 6340437
    [No Abstract]   [Full Text] [Related]  

  • 9. Heterogeneity in chemotaxis of neutrophils with different densities.
    Miyagawa H; Okada C; Sugiyama H; Hopp RJ; Bewtra AK; Townley RG
    Biochem Biophys Res Commun; 1990 Nov; 172(3):1094-9. PubMed ID: 2244894
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A macrophage chemotactic factor sharing common antigenicity with immunoglobulin G from DNP-ascaris extract-induced skin lesion in guinea-pig.
    Honda M; Hirashima M; Nishiura M; Hayashi H
    Virchows Arch B Cell Pathol; 1978 Jun; 27(4):317-33. PubMed ID: 98903
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chemotactic monoclonal antibody conjugates: a comparison of four different f-Met-peptide-conjugates.
    Obrist R; Schmidli J; Obrecht JP
    Biochem Biophys Res Commun; 1988 Sep; 155(3):1139-44. PubMed ID: 3263121
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-idiotype as antibody against the formyl peptide chemotaxis receptor of the neutrophil.
    Marasco WA; Becker EL
    J Immunol; 1982 Feb; 128(2):963-8. PubMed ID: 7054297
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chemotactic peptide from ropalidian wasp as well as the authentic chemotactic tripeptide stimulates two distinct pathways in neutrophils, but the [LYS7] analog does only one of them.
    Koike M; Nagashima K; Saito K; Nakanishi M; Fujino M; Nakajima T
    Biochem Biophys Res Commun; 1991 Feb; 175(1):165-72. PubMed ID: 1847803
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Coexistence of a chemotactic factor and a retroviral P15E-related chemotaxis inhibitor in human tumor cell culture supernatants.
    Wang JM; Cianciolo GJ; Snyderman R; Mantovani A
    J Immunol; 1986 Oct; 137(8):2726-32. PubMed ID: 3760573
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibodies against the N-terminus of IL-8 receptor A inhibit neutrophil chemotaxis.
    Quan JM; Martin TR; Rosenberg GB; Foster DC; Whitmore T; Goodman RB
    Biochem Biophys Res Commun; 1996 Feb; 219(2):405-11. PubMed ID: 8605000
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Eosinophil infiltration and enhancement of airway reactivity by leukocyte chemotactic factor, formyl-methionyl-leucyl-phenylalanine (fMLP), in guinea pigs.
    Amagai M; Ohashi Y; Makino S
    Arerugi; 1992 Nov; 41(11):1547-60. PubMed ID: 1492788
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of in vitro guinea pig eosinophil chemotaxis by leukotriene B4 antagonist U-75,302.
    Taylor BM; Czuk CI; Brunden MN; Wishka DG; Morris J; Sun FF
    Adv Prostaglandin Thromboxane Leukot Res; 1989; 19():195-8. PubMed ID: 2546384
    [No Abstract]   [Full Text] [Related]  

  • 18. Selective inhibition of human neutrophil chemotaxis to N-formyl-methionyl-leucyl-phenylalanine by sulfones.
    Harvath L; Yancey KB; Katz SI
    J Immunol; 1986 Aug; 137(4):1305-11. PubMed ID: 3016092
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acute and subacute toxicity of chemotactic conjugates between monoclonal antibody and fMet-Leu-Phe in humans: a phase I clinical trial.
    Obrist R; Schmidli J; Müller R; Gallati H; Obrecht JP
    Cancer Immunol Immunother; 1991; 32(6):406-8. PubMed ID: 2007248
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Demonstration of a chemotactic factor receptor on macrophages.
    Snyderman R; Fudman EJ
    J Immunol; 1980 Jun; 124(6):2754-7. PubMed ID: 7373048
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.